le_kim91

LMNL up and away

做多
NASDAQ:LMNL   Liminal BioSciences Inc.
new catalyst on 4 th of june, FDA approval on ryplazim. this stock has been very weak for a while now. big movement imminent on monday

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。